Back to search

Netherlands· NL-efd960be04ad

Cozaar Plus 100 mg/12,5 mg filmomhulde tabletten

A losartan und diuretika product containing hydrochloorthiazide + losartan kalium, registered in Netherlands by N.V. Organon. The same ATC class is registered in 12 of our 19 countries.

ATC C09DA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCozaar Plus 100 mg/12,5 mg filmomhuld…ATCC09DA01REGISTER NO.NL-efd960be04adPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Losartan und diuretika is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DA01 (losartan und diuretika), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Losartan und diuretika · ATC C09DA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROCHLOORTHIAZIDE + LOSARTAN KALIUM
Manufacturer
N.V. Organon
Country
Netherlands (NL)
ATC code
C09DA01
ATC class
Losartan und Diuretika
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    32433

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for losartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Losartan und diuretika · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e7cdd960-080f-41e4-9832-7c443ae0b3ec
GET /v1/drugs/e7cdd960-080f-41e4-9832-7c443ae0b3ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h32433_smpc.pdf",
  "strength": null,
  "atc_label": "Losartan And Diuretics",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg32433",
  "excipients": [
    "CARNAUBAWAS (E 903)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TITANII DIOXIDUM (LN)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "HYDROCHLOORTHIAZIDE",
    "LOSARTAN KALIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h32433.pdf",
  "authorised_at": "2006/08/09",
  "procedure_number": "NL/H/1458/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "32433",
  "additional_monitoring": "N"
}

See everything about losartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.